Search

Background Nearly 15% colorectal cancer (CRC) patients received ileostomy, while surgical site infection (SSI) is a common complication after ileostomy wound closure. Purse-string closure was reported to reduce SSI rate in ileostomy wound closure compared with conventional linear closure, but had never been systematically reported in CRC patients. The present study aimed to compare the short-term outcomes between purse-string and conventional closure in Chinese CRC patients. Patients and methods A total of 57 CRC patients underwent ileostomy wounds closure in the Second Affiliated Hospital of Zhejiang University during November, 2015 and October, 2017 were retrospectively reviewed. Twenty-nine received purse-string closure while the others received conventional closure. The short-term outcomes including SSI rate, scar length, pain score and hospital stay were reviewed and analyzed. Results There were no significant differences in the characteristics of the patients between two groups. The SSI rate was similar within two groups (10.3% vs 10.7%, p = 1.000). The purse-string closure group had a significantly short scar length (1.66 cm vs 5.30 cm, p Conclusion The present study did not find superiority of Purse-string closure in SSI rate control. It seemed only had a cosmetic effect according to its shorter scar length.

Background and purpose Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present. This study aimed to explore the correlation between Ki-67 LI and apparent diffusion coefficient (ADC) parameters and to predict the level of Ki-67 LI noninvasively before surgery by multiple MRI characteristics. Methods Preoperative MRI data of 166 patients with pathologically confirmed glioma in our hospital from 2016 to 2020 were retrospectively analyzed. The cut-off point of Ki-67 LI for glioma grading was defined. The differences in MRI characteristics were compared between the low and high Ki-67 LI groups. The receiver operating characteristic (ROC) curve was used to estimate the accuracy of each ADC parameter in predicting the Ki-67 level, and finally a multivariate logistic regression model was constructed based on the results of ROC analysis. Results ADCmin, ADCmean, rADCmin, rADCmean and Ki-67 LI showed a negative correlation (r = − 0.478, r = − 0.369, r = − 0.488, r = − 0.388, all P P P Conclusions There was a negative correlation between ADC parameters and Ki-67 LI, and the multivariate logistic regression model combined with peritumoral edema and ADC parameters could improve the prediction ability of Ki-67 LI.

The identification of high recurrence risk stage II colon cancer patients was critical to adjuvant chemotherapy decision. However, current definition of high-risk features remains inadequate. This study aimed to construct a model for predicting recurrence risk based on tumor enhancement ratio (TER) on abdominal contrast-enhanced CT scan.282 stage II colon cancer patients were included and randomly divided into training and validation sets in the ratio of 7:3. TER was calculated using maximum tumor attenuation value in contrast-enhanced CT scan divided by the minimum. Kaplan-Meier survival analyses were adopted to evaluate the prognostic value of variables. A model based on TER was built to predict recurrence risk through the LASSO Cox model. The recurrence risk score of patients was calculated based on this model.The optimal cut-off value of TER was 1.83 derived from the time-dependent ROC (tdROC) curve. Patients with high-TER showed increasingly poorer disease-free survival (DFS) in both training (p 0.001) and validation (p 0.001) sets. A model was built based on TER demonstrated satisfactory performance to recurrence risk prediction (C-index: 0.784 in the training set and 0.725 in the validation set). Patients were regrouped into modified high-risk and non-high risk according to recurrence risk score (cut-off value: 1.75) and a significant DFS difference was observed (training set: p 0.001; validation set: p 0.001).TER can serve as a high-risk feature of stage II colon cancer. And a model based on TER provided a new approach to assess recurrence risk of stage II disease.

A two-step strategy to improve the thermoplasticity of bamboo powder (BP) by the combination of hydrothermal pretreatment (BP-LHW) and propargyl modification (BP-PB/BP-LHW-PB) in a heterogeneous system was developed in this research. It was observed that the hydrothermal pretreatment has a positive impact on the alkyne-functionalized BP-LHW, resulting in substantial change including the etherification of BP-LHW with propargyl bromide, breaking of crystalline phase of the cellulose fraction. Besides, the modified sample is significantly changed in the apparent morphology and reduced in the thermal stability and glass transition temperature (Tg). The Tg is attributed to the increase of free volume due to the increase of propargyl concentration in the modified samples. These results revealed that the combination of propargyl group into pretreated BP is an efficacious way to ameliorate the thermoplasticity. Notably, the thermoplasticity of BP-LHW-PB with high concentration of propargyl is significantly enhanced compared to BP-PB, which is owed to the enhanced molecular mobility resulting from the reduced interaction forces between the cellulose molecular. Herein, the application way that the building a "clickable" alkyne platform in BP to obtain multifunctional materials will be broadened in bamboo-based materials. The bio-based material with improved thermoplasticity was prepared by grafting propargyl bromide onto bamboo powder.

Purpose Nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors (COXibs) inhibit the progression of endometrial cancer, ovarian cancer and cervical cancer. However, concerning the adverse effects of NSAIDs and COXibs, it is still urgent and necessary to explore novel and specific anti-inflammation targets for potential chemoprevention. The signaling of cyclooxygenase 2-prostaglandin E2-prostaglandin E2 receptors (COX-2-PGE2-EPs) is the central inflammatory pathway involved in the gynecological carcinogenesis. Methods Literature searches were performed to the function of COX-2-PGE2-EPs in gynecological malignancies. Results This review provides an overview of the current knowledge of COX-2-PGE2-EPs signaling in endometrial cancer, ovarian cancer and cervical cancer. Many studies demonstrated the upregulated expression of the whole signaling pathway in gynecological malignancies and some focused on the function of COX-2 and cAMP-linked EP2/EP4 and EP3 signaling pathway in gynecological cancer. By contrast, roles of EP1 and the exact pathological mechanisms have not been completely clarified. The studies concerning EP receptors in gynecological cancers highlight the potential advantage of combining COX enzyme inhibitors with EP receptor antagonists as therapeutic agents in gynecological cancers. Conclusion EPs represent promising anti-inflammation biomarkers for gynecological cancer and may be novel treatment targets in the near future.

Human liver cancers, including hepatocellular carcinomas and intra-hepatic cholangiocarcinomas, are often diagnosed late with poor prognosis. A better understanding of cancer initiation could provide potential preventive therapies and increase survival. Models for studying human liver cancer initiation are largely missing. Here, using directly reprogrammed human hepatocytes (hiHeps) and inactivation of p53 and RB, we established organoids possessing liver architecture and function. HiHep organoids were genetically engineered to model the initial alterations in human liver cancers. Bona fide hepatocellular carcinomas were developed by overexpressing c-Myc. Excessive mitochondrion-endoplasmic reticulum coupling induced by c-Myc facilitated hepatocellular carcinoma initiation and seemed to be a target of preventive treatment. Furthermore, through the analysis of human intra-hepatic cholangiocarcinoma-enriched mutations, we demonstrate that the RAS-induced lineage conversion from hepatocytes to intra-hepatic cholangiocarcinoma cells can be prevented by the combined inhibition of Notch and JAK-STAT. Together, hiHep organoids represent a system that can be genetically manipulated to model cancer initiation and identify potential preventive therapies.

The proteins BAFF, ST6GALNAC2, C1GALT1, and COSMC in peripheral blood mononuclear cells (PBMCs) and plasma levels of IgA1 and galactose-deficient IgA1 (Gd-IgA1) are potential biomarkers for IgAN nephropathy. In this study, we comparatively studied the changes of those biomarkers before and after tonsillectomy.Peripheral blood samples were obtained from 16 IgAN patients with pre- and post-tonsillectomy. IgAN was diagnosed based on results from analysis of percutaneous renal biopsy tissue. Peripheral blood samples from three patients without renal diseases (non-IgAN), before and after tonsillectomy, and 16 healthy controls were also examined. BAFF, ST6GALNAC2, C1GALT1, and COSMC mRNA levels in PBMCs were detected using real-time PCR. Plasma IgA1 content was measured by ELISA. Gd-IgA1 levels were determined using the VV lectin-ELISA method.BAFF, ST6GALNAC2, C1GALT1, and COSMC mRNA levels and the plasma concentrations of IgA1 and Gd-IgA1 in IgAN patients before tonsillectomy were significantly higher than those in healthy controls (P 0.05). Tonsillectomy significantly increased the expression of BAFF and ST6GALNAC2, and plasma IgA1 level, while it downregulated that of C1GALT1 and COSMC (P 0.05). However, in non-IgAN patients, tonsillectomy did not affect the mRNA levels of BAFF, ST6GALNAC2, C1GALT1, and COSMC, plasma IgA1 content and Gd-IgA1 level. Positive correlations were established between BAFF and IgA1 (r = 0.604, P 0.01) and between ST6GALNAC2 and Gd-IgA1 (r = 0.623, P 0.01).Tonsillectomy changes the mRNA levels of BAFF, ST6GALNAC2, C1GALT1, and COSMC in PBMCs, as well as the plasma IgA1 level in IgAN patients. BAFF and ST6GALNAC2 might regulate IgA1 secretion and O-glycosylation.

A series of compression tests were conducted on 150 groups of cement paste specimens with side lengths ranging from 40 mm to 200 mm. The specimens include cube specimens and prism specimens with height to width ratio of 2. The experiment results show that size effect exists in the cubic compressive strength and prismatic compressive strength of the cement paste, and larger specimens resist less in terms of strength than smaller ones. The cubic compressive strength and the prismatic compressive strength of the specimens with side length of 200 mm are respectively about 91% and 89% of the compressive strength of the specimens with the side length of 40 mm. Water to binder ratio has a significant influence on the size effect of the compressive strengths of the cement paste. With a decrease in the water to binder ratio, the size effect is significantly enhanced. When the water to binder ratio is 0.2, the size effects of the cubic compressive strength and the prismatic compressive strength of the cement paste are 1.6 and 1.4 times stronger than those of a water to binder ratio of 0.6. Furthermore, a series of formulas are proposed to calculate the size effect of the cubic compressive strength and the prismatic compressive strength of cement paste, and the results of the size effect predicted by the formulas are in good agreement with the experiment results.

Scientific Reports 6: Article number: 38012; published online: 29 November 2016; updated: 10 February 2017. The Acknowledgements section in this Article is incomplete. ‘The work was supported by grants from the National Natural Science Foundation of China (Grant Nos 81400371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

The objective of the present study was to systematically assess the association between dioxin/2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and cancer incidence and mortality. Systematic literature searches were conducted until July 2015 in Pubmed, Embase and Cochrane library to identify relevant studies. A random-effects model was applied to estimate the pooled odds ratio (OR), risk ratio (RR), standard incidence ratio (SIR) or standard mortality ratio (SMR) for cancer incidence or mortality. In addition, dose-response, meta-regression, subgroup, and publication bias analyses were conducted. Thirty-one studies involving 29,605 cancer cases and 3,478,748 participants were included. Higher external exposure level of TCDD was significantly associated with all cancer mortality (pooled SMR = 1.09, 95% CI: 1.01–1.19, p = 0.04), but not all cancer incidence (pooled RR = 1.01, 95% CI: 0.97–1.06, p = 0.49). Higher blood level of TCDD was both significantly associated with all cancer incidence (pooled RR = 1.57, 95% CI: 1.21–2.04, p = 0.001) and all cancer mortality (pooled SMR = 1.45, 95% CI: 1.25–1.69, p